Kura Oncology Financial Overview
Kura Oncology's market cap is currently $925.00M. The company's EPS TTM is $-0.85; its P/E ratio is ―; Kura Oncology is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
